selected scholarly activity
-
academic article
- Guideline for the Initial Management of Small Cell Lung Cancer (Limited and Extensive Stage) and the Role of Thoracic Radiotherapy and First-line Chemotherapy. Clinical Oncology Comparative Haematology International. 30:658-666. 2018
- Pulmonary nodules as incidental findings. CMAJ. 190:E167-E167. 2018
- Appropriate Use Criteria for18F-FDG PET/CT in Restaging and Treatment Response Assessment of Malignant Disease. Journal of Nuclear Medicine. 58:2026-2037. 2017
- Bone Health and Bone-Targeted Therapies for Nonmetastatic Prostate Cancer. Annals of Internal Medicine. 167:341-341. 2017
- Correlation of 18 F-FDG PET and MRI Apparent Diffusion Coefficient Histogram Metrics with Survival in Diffuse Intrinsic Pontine Glioma: A Report from the Pediatric Brain Tumor Consortium. Journal of Nuclear Medicine. 58:1264-1269. 2017
- Bone Health and Bone-targeted Therapies for Prostate Cancer: a Programme in Evidence-based Care — Cancer Care Ontario Clinical Practice Guideline. Clinical Oncology Comparative Haematology International. 29:348-355. 2017
- Postoperative Adjuvant Systemic Therapy in Completely Resected Non–Small-Cell Lung Cancer: A Systematic Review. Clinical Lung Cancer. 18:259-273.e8. 2017
- Joint reconstruction of Ictal/inter-ictal SPECT data for improved epileptic foci localization. Medical Physics. 44:1437-1444. 2017
- Self-management education interventions for patients with cancer: a systematic review. Supportive Care in Cancer. 25:1323-1355. 2017
- Response Assessment Criteria and Their Applications in Lymphoma: Part 2. Journal of Nuclear Medicine. 58:13-22. 2017
- SNMMI Comment on the 2016 Society of Surgical Oncology “Choosing Wisely” Recommendation on the Use of PET/CT in Colorectal Cancer. Journal of Nuclear Medicine. 58:11-12. 2017
- Approach to evaluation of fever in ambulatory cancer patients receiving chemotherapy: A systematic review. Cancer Treatment Reviews. 51:35-45. 2016
- Evidence-based guideline recommendations on treatment strategies for localized Ewing's sarcoma of bone following neo-adjuvant chemotherapy. Surgical Oncology. 25:92-97. 2016
- Response Assessment Criteria and Their Applications in Lymphoma: Part 1. Journal of Nuclear Medicine. 57:928-935. 2016
- Disease volume and distribution as drivers of treatment decisions in metastatic prostate cancer: From chemohormonal therapy to stereotactic ablative radiotherapy of oligometastases. Urologic Oncology: Seminars and Original Investigations Seminars in Urologic Oncology. 34:225-232. 2016
- Imaging Biomarkers in Immunotherapy. Biomarkers in Cancer. 8s2:BIC.S31805-BIC.S31805. 2016
- Targeted Radionuclide Therapy: Practical Applications and Future Prospects. Biomarkers in Cancer. 8s2:BIC.S31804-BIC.S31804. 2016
- Proceedings of the Second NCI-SNMMI Workshop on Targeted Radionuclide Therapy. Journal of Nuclear Medicine. 56:1119-1129. 2015
- Beyond current guidelines: reduction in minimum administered radiopharmaceutical activity with preserved diagnostic image quality in pediatric hepatobiliary scintigraphy. European Journal of Nuclear Medicine and Molecular Imaging European Journal of Nuclear Medicine. 41:2346-2353. 2014
- Imaging, procedural and clinical variables associated with tumor yield on bone biopsy in metastatic castration-resistant prostate cancer. Prostate Cancer and Prostatic Diseases. 17:325-331. 2014
- Metabolic response by FDG-PET to imatinib correlates with exon 11 KIT mutation and predicts outcome in patients with mucosal melanoma. Cancer Imaging. 14:30. 2014
- 18F-FDG PET and MR Imaging Associations Across a Spectrum of Pediatric Brain Tumors: A Report from the Pediatric Brain Tumor Consortium. Journal of Nuclear Medicine. 55:1473-1480. 2014
- Guideline for referral of patients with suspected colorectal cancer by family physicians and other primary care providers.. Canadian Family Physician. 60:717-e390. 2014
- Guideline for referral of patients with suspected lung cancer by family physicians and other primary care providers.. Canadian Family Physician. 60:711-e382. 2014
- Systematic review of clinical features of suspected colorectal cancer in primary care.. Canadian Family Physician. 60:e405-e415. 2014
- Systematic review of guidelines for the management of suspected lung cancer in primary care.. Canadian Family Physician. 60:e395-e404. 2014
- Abdomen. PET Clinics. 9:169-183. 2014
- Targeted Radionuclide Therapy: Proceedings of a Joint Workshop Hosted by the National Cancer Institute and the Society of Nuclear Medicine and Molecular Imaging. Journal of Nuclear Medicine. 55:337-348. 2014
- Imaging in Prostate Carcinoma. Hematology/Oncology Clinics of North America. 27:1163-1187. 2013
- Anal carcinoma: FDG PET/CT in staging, response evaluation, and follow-up. Abdominal Imaging Gastrointestinal Radiology. 38:728-735. 2013
- Update on Imaging of Vulvar Squamous Cell Carcinoma. American Journal of Roentgenology. 201:W147-W157. 2013
- Imaging Features of Primary and Secondary Adult Rhabdomyosarcoma. American Journal of Roentgenology. 199:W694-W703. 2012
- MRI for Evaluation of Myeloid Sarcoma in Adults: A Single-Institution 10-Year Experience. American Journal of Roentgenology. 199:1193-1198. 2012
- PET/CT and Renal Pathology: A Blind Spot for Radiologists? Part 1, Primary Pathology. American Journal of Roentgenology. 199:W163-W167. 2012
- PET/CT and Renal Pathology: A Blind Spot for Radiologists? Part 2—Lymphoma, Leukemia, and Metastatic Disease. American Journal of Roentgenology. 199:W168-W174. 2012
- Multimodality imaging in amyloidosis. Cancer Imaging. 12:109-117. 2012
- Esophageal gastrointestinal stromal tumor: report of 7 patients. Cancer Imaging. 12:100-108. 2012
- Pheochromocytoma and paraganglioma: nimaging characteristics. Cancer Imaging. 12:153-162. 2012
- Imaging in Renal Cell Carcinoma. Hematology/Oncology Clinics of North America. 25:687-715. 2011
- Imaging of Liposarcoma: Classification, Patterns of Tumor Recurrence, and Response to Treatment. American Journal of Roentgenology. 197:W37-W43. 2011
- Nuclear Medicine in the First Year of Life. Journal of Nuclear Medicine. 52:905-925. 2011
- End-of-treatment but not interim PET scan predicts outcome in nonbulky limited-stage Hodgkin's lymphoma. Annals of Oncology. 22:910-915. 2011
- Skeletal Scintigraphy in Pediatric Sports Medicine. American Journal of Roentgenology. 195:1212-1219. 2010
- The value of SPECT in the detection of stress injury to the pars interarticularis in patients with low back pain. Journal of Orthopaedic Surgery and Research. 5:13-13. 2010
- Endovascular Repair of Traumatic Mesocaval Fistula. Journal of Vascular and Interventional Radiology. 19:1659-1661. 2008
- Contrast Echocardiography Grading Predicts Pulmonary Arteriovenous Malformations on CT. Chest. 132:18-23. 2007
- Sonography for assessment of haemophilic arthropathy in children: a systematic protocol. Haemophilia. 13:293-304. 2007
- Systemic therapy for advanced uterine sarcoma: A systematic review of the literature. Gynecologic Oncology. 97:624-637. 2005
-
conference paper
- Stereotactic ablative radiotherapy (SABR) for oligoprogressive metastatic castration-resistant prostate cancer (mCRPC) during abiraterone therapy: A phase I study. Annals of Oncology. 2017
- An Approach to New Oncologic PET Agent Development. Journal of Nuclear Medicine. 2017
- Phase 1 study with expansion cohorts of cabozantinib (C) plus abiraterone (A) in metastatic castration resistant prostate cancer (mCRPC): Investigator-sponsored study.. Journal of Clinical Oncology. 2015
- Evaluation of refractory epilepsy in children using 3D-SSP (NEUROSTAT) and FDG-PET. Journal of Nuclear Medicine. 2014
- PET and MRI associations across a spectrum of pediatric brain tumors: A report from the Pediatric Brain Tumor Consortium (PBTC). Journal of Nuclear Medicine. 2014
- Prognostic value of baseline evaluation of FDG and NaF PET/CT in castrate-resistant prostate cancer (CRPC): Early results from a prospective phase 1 trial. Journal of Nuclear Medicine. 2014
- A practical approach to PET/MRI: Common abdominal pathology in oncology. Journal of Nuclear Medicine. 2013
- Abstract LB-166: Cabozantinib (cabo) + abiraterone (abi) combination therapy in castration resistant prostate cancer (CRPC): preclinical evaluation and interim results of an investigator-sponsored phase 1 clinical study.. Cancer Research. 2013
- Beyond Dose Guidelines: Lower Minimum Radiopharmaceutical Administered Doses in Pediatric Hepatobiliary Scintigraphy: Application of Enhanced Planar Processing.. European Journal of Nuclear Medicine and Molecular Imaging European Journal of Nuclear Medicine. S237-S237. 2012
- Role of CT, MRI, and PET/CT in Management of Myeloid Sarcoma With Clinical and Pathologic Correlation. American Journal of Roentgenology. 2012
- The Utility of Bone Scintigraphy in Pediatric Patients (CME Credit Available). American Journal of Roentgenology. 2009